Skip to main content Accessibility help
×
Home

Technology Transfer in the Interwar U.S. Pharmaceutical Sector: The Case of E. Merck of Darmstadt and Merck & Co., Rahway, New Jersey

  • ANDREW GODLEY (a1), MARRISA JOSEPH (a2) and DAVID LESLIE-HUGHES (a3)

Abstract

This is a case study of the U.S. pharmaceutical producer, Merck & Co. By 1940 this was one of the leading pharmaceutical producers in the United States, and the company went on to become one of the global industry leaders after World War II. It was founded in 1891 as the U.S. subsidiary of a much larger German pharmaceutical company, E. Merck of Darmstadt. The existing understanding of Merck & Co.’s history emphasizes how it was reacquired by the American branch of the Merck family after wartime sequestration, and from then onward it pursued a path of development separate from its former parent. This article revisits that history of the company and shows how the two Mercks began to cooperate and share technology and manufacturing know-how during the 1930s, something that was particularly to the advantage of Merck & Co.

Copyright

References

Hide All
Abbott Laboratories. The Abbott Almanac: One Hundred Years of Commitment to Quality Health Care, Elmsford, NY: Benjamin, 1988.
Bayer, . Fifty Years, 1888–1938, of Bayer Remedies. Leverkusen: Bayer/IGF, 1938.
Beer, J. J. The Emergence of the German Dye Industry. Urbana: University of Illinois Press, 1959.
Bernschneider-Reif, Sabine, Huber, Walter, and Possehl, Ingunn. Was der Mensch thun kann…’ The History of Merck—The World’s Oldest Pharmaceutical Chemical Company. Darmstadt: Merck KGaA, 2002.
Carlisle, Robert D. A Century of Caring: The Upjohn Story . Elmsford, NY: Benjamin, 1987.
Chandler, A. D. Visible Hand. Cambridge, MA: Belknap, 1977.
Chandler, A. D. Scale and Scope. Cambridge, MA: Belknap, 1990.
Chandler, A. D. Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries. Cambridge, MA: Harvard University Press, 2005.
Church, Roy, and Tansey, E. M.. Burroughs Wellcome: Knowledge, Trust, Profit and the Transformation of the British Pharmaceutical Industry, 1880–1940. Lancaster, UK: Crucible, 2007.
Davies, Wyndham. The Pharmaceutical Industry: A Personal Study. Oxford: Pergamon, 1967.
Deeson, Tony. Parke, Davis in Britain, the First Hundred Years . Eastleigh, UK: Parke Davis Ltd., 1995.
Derdak, T., ed. International Directory of Company Histories. London: St. James Press, 1988.
Franko, Lawrence, The European Multinationals: A Renewed Challenge to American and British Big Business. London: Harper & Row, 1976.
Galambos, Lou, and Sewell, Jane. Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford. Cambridge: Cambridge University Press, 1995.
Haber, L. F. The Chemical Industry During the Nineteenth Century . Oxford: Oxford University Press, 1958.
Kobrak, Christopher. National Cultures and International Competition: The Experience of Schering AG, 1851–1950 . Cambridge: Cambridge University Press, 2002.
Kogan, Herman. The Long White Line: The Story of Abbott Laboratories. New York: Random House, 1963.
Lesch, John. The First Miracle Drugs. How Sulfa Drugs Transformed Medicine. Oxford: Oxford University Press, 2007.
Madison, James, Eli Lilly: A Life, 1885–1977. Bloomington: Indiana Historical Society, 2006.
Mahoney, Tom. Merchants of Life. An Account of the American Pharmaceutical Industry New York: Harper, 1959.
Mines, Samuel. Pfizer… An Informal History. New York: Pfizer Inc., 1978.
Quirke, Vivienne. Collaboration in the Pharmaceutical Industry. Changing Relationships in Britain and France, 1935–1965. Abingdon, UK: Routledge, 2008.
Shook, Robert. Miracle Medicines: Seven Lifesaving Drugs and the People Who Created Them . New York: Random House, 2007.
Slinn, J. A History of May & Baker, 1834–1984. Cambridge, UK: Hobsons, 1984.
Slinn, J. Abbott Laboratories in the UK. Cambridge, UK: Granta, 1999.
Steen, Kathryn. The American Synthetic Organic Chemicals Industry: War and Politics, 1910–1930. Chapel Hill, NC: University of North Carolina Press, 2014.
Sturchio, Jeffrey, and Galambos, Lou. Values and Visions. A Merck Century. Whitehouse Station, NJ: Merck & Co. Inc, 1991.
Swann, John P. Academic Scientists and the Pharmaceutical Industry: Co-operative Research in Twentieth Century America. Baltimore, MD: Johns Hopkins University Press, 1988.
Wilkins, Mira. The History of Foreign Investment in the United States, 1914–1945. Cambridge MA: Harvard University Press, 2004.
Athreye, Suma, and Godley, Andrew C.. “Internationalisation and Technological Leapfrogging in the Pharmaceutical Industry.” Industrial and Corporate Change, 18, no. 2 (2009): 295323.
Broadberry, Stephen. “The Performance of Manufacturing.” In The Cambridge Economic History of Modern Britain, edited by Floud, Roderick and Johnson, Paul. Cambridge: Cambridge University Press, 2004, pp. 5783.
Burhop, Carsten. “Max Planck Pre-prints: Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck.” Preprint. Bonn: Max Planck Institute for Research on Collective Goods, 2008/3.
Burhop, Carsten. “Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck.” Business History Review 83, no. 3 (2009): 475503.
Cantwell, John A. “Historical Trends in International Patterns of Technological Innovation.” In New Perspectives on the Late Victorian Economy, edited by Foreman-Peck, James. Cambridge: University Press, 1991, pp. 3772.
Corley, T. A. B., and Godley, A. C.. “The Veterinary Medicines Industry in Britain, 1900–2000.Economic History Review, 64, no. 3 (2011): 832854.
Corley, T. A. B., and Godley, A. C.. “Veterinary Medicines in Britain: Output and Industry Organisation Since 1900.” Medical History , 55 (2011): 361364.
Cramer, Tobias. “Building the ‘World’s Pharmacy’: The Rise of the German Pharmaceutical Industry, 1871–1914.” Business History Review, 89, no. 1 (2015): 4573.
Finucane, Brendan T. “Canadian Contributions to the Introduction and Use of Divinyl Ether.” Canadian Journal of Anesthesia, 55, no. 12 (2008): 853858.
Fisher, J. C.Basic Research in Industry.” Science, 129, no. 3364 (1959): 16531657.
Furman, Jeffrey L., and McGarvie, Megan J.. “Academic Science and the Birth of Industrial Research.” Journal of Economic Behavior and Organization, 63 (2007): 756776.
Galambos, Lou, and Sturchio, Jeffrey. “Transnational Investment: The Merck Experience, 1891–1925.” Zeitschrift fur Uniternehmergeschichte, 81 (1994): 227243.
Godley, Andrew. “Entrepreneurial Opportunities, Implicit Contracts and Market Making for Complex Consumer Goods.” Strategic Entrepreneurship Journal, 7, no. 4 (2013): 273287.
Godley, Andrew. “The Emergence of Agribusiness in Europe and the Development of the Western European broiler chicken industry, 1945–1973.” Agricultural History Review, 62 (2014): 292313
Godley, Andrew and Casson, Mark, “‘Doctor, Doctor ’ Entrepreneurial Diagnosis and Market Making.” Journal of Institutional Economics, 11 (2015): 601621
Gortler, Leon. “Merck in America: The First 70 Years from Fine Chemicals to Pharmaceutical Giant.” Bulletin of the History of Chemistry 25 (2000): 19.
Hannah, Les. “Logistics, Market Size, and Giant Plants in the Early Twentieth Century: A Global View.” Journal of Economic History, 68, no. 1 (2008): 4679.
Hertner, P.German Multinational Enterprise Before 1914: Some Case Studies.” In Multinationals: Theory and History, edited by Hertner, P. and Jones, G., 113133. Aldershot, UK: Ashgate, 1987.
Hugill, Peter J., and Bachmann., VeitThe Route to the Techno-Industrial World Economy and the Transfer of German Organic Chemistry to America Before, During and Immediately After World War.” Comparative Technology Transfer and Society, 3, no. 2 (2005): 158186.
Indianapolis Star (Edelhart, Courtenay). “The Economy: Eli Lilly & Co. A Firm Foundation.” Indianapolis Star, April 18, 1999.
Kline, Ronald. “Constructing ‘Technology’ as ‘Applied Science’: Public Rhetoric of Scientists and Engineers in the United States, 1880–1945.” Isis, 86, no. 2 (1995): 194221.
Kobrak, Christopher. “Issues in German Corporate Governance: A Note on the History of Schering AG and the Culture of German Capitalism.” Paper presented to European International Business Academy, Stockholm, Sweden, December 1996.
Lee, Jeho. “Innovation and Strategic Divergence: An Empirical Study of the U.S. Pharmaceutical Industry from 1920 to 1960.” Management Science, 49, no. 2 (2003): 143159.
Liebenau, Jonathan. “Industrial R&D in Pharmaceutical Firms in the Early Twentieth Century.” Business History, 26, no. 3 (1984): 329346.
Liebenau, Jonathan. Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry. Basingstoke, UK: Macmillan, 1984.
Liebenau, Jonathan. “Detail Men: Marketing Medicine.” In History, Bagmen and Markets, edited by Davenport-Hines, R. P. T.. Aldershot, UK: Gower, 1986, pp. 82101.
Liebenau, Jonathan. “Modernizing the Business of Health: Pharmaceuticals in Britain, in Comparison with Germany and the USA, 1890–1940.” Industrial and Corporate Change, 22, no. 3 (2013): 807847.
Lynn, Matthew. The Billion Dollar Battle: Merck Versus Glaxo . London: Heinemann, 1991.
Owens, Larry. “MIT and the Federal ‘Angel’: Academic R&D and Federal–Private Cooperation Before World War II.” Isis, 81, no. 2 (1990): 188213.
Sanderson, Michael. “Research and the Firm in British Industry, 1919–39.” Science Studies, 2 (1972): 107151.
Scheiding, Tom. “Building the Scholarly Society Infrastructure in Physics in Interwar America.” Studies in History and Philosophy of Modern Physics , 44, no. 4 (2013): 450463.
Schneider, Michael. “Das Wissenschaftlichen Unternehmen. Zur chemisch-pharmazeutischen Forschung bei E. Merck, Darmstadt, ca. 1900–bis 1930.” Zeitschrift fur Unternehmengeschichte , 62, no. 2 (2017): 163203.
Sturchio, Jeffrey, and Galambos, Lou. “The German Connection: Merck and the Flow of Knowledge from Germany to the United States, 1880–1930.” Business and Economic History On-Line 9 (2011): 114.
Time magazine, various issues, including August 26, 1929, Time “Drug Disinc,” Vol. XXII No. 2.
White, Michael. “US Alien Property Custodian Patent Documents: A Legacy Prior Art Collection from World War II—Part 1. History.” World Patent Information 29, no. 4 (2007): 339345.
Frontline various issues, e.g., 14 (January–February) 1969, 20 (March–April), 1970. Merck Archives, Whitehouse Station, NJ.
Galambos, Lou, and Sturchio, Jeffrey. “Sustaining Innovation: Critical Transitions at Merck & Co., Inc.” Unpublished manuscript, August 8, 1997. Merck Archives, Whitehouse Station, NJ.
Gortler, Leon. “Interview with Adolphe Rosengarten.” Merck Archives, Whitehouse Station, NJ
Gortler, Leon. “Interview with Jack Connor.” Merck Archives, Whitehouse Station, NJ.
Merck annual reports, various years. Merck Archives, Whitehouse Station, NJ.
Merck Review, various issues. Merck Archives, Whitehouse Station, NJ.
Sharp & Dohme. “The History of Sharp & Dohme: From Apothecary Shop to International Institution.” No author, no date but ca. 1946. Merck Archives, Whitehouse Station, NJ
Chemical Heritage Foundation, Philadelphia, PA
Merck KGaA, Archives, Darmstadt, Germany (EMA)
Merck & Co., Inc., Whitehouse Station, NJ (MA)
U.S. National Archives, MD

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed